When a healthcare startup reaches the point of acquisition or merger, founders often discover that the corporate structure they chose years ago has become the single most important factor in determining whether a deal closes, how long it takes, and what their company is worth. For digital health companies, the MSO-PC structure is not just a compliance requirement. It is a strategic asset that directly impacts exit outcomes.

This article explains how acquirers evaluate healthcare corporate structures, what makes an MSO-PC arrangement clean or messy, and how to position your company for the best possible exit.

How Acquirers Evaluate Healthcare Companies

Healthcare M&A differs from standard tech acquisitions in one fundamental way: regulatory risk. An acquirer buying a SaaS company worries about churn and technical debt. An acquirer buying a healthcare company worries about those things plus the possibility that the entire business could be deemed illegal under state corporate practice of medicine laws.

Sophisticated acquirers, whether they are private equity firms, hospital systems, or larger digital health companies, have healthcare regulatory counsel who will scrutinize your structure from the very first meeting. They are looking for:

We have seen deals fall apart in due diligence because the target company had an MSO-PC structure on paper but had never actually operated as two separate entities. The MSO was directing clinical decisions, the physician owner had no real authority, and the management fees bore no relationship to fair market value.

What Makes an MSO-PC Structure "Clean"

A clean MSO-PC structure is one that will survive regulatory scrutiny during due diligence without requiring significant restructuring. The hallmarks of a clean structure include:

Proper Entity Formation

The PC must be properly formed in each state where it practices medicine, with a licensed physician as the legal owner. The MSO should be a separate legal entity, typically a Delaware LLC or C-Corp, with its own EIN, bank accounts, and operating agreements.

Fair Market Value Management Fees

The management services agreement must specify fees that reflect the actual value of services provided by the MSO. Percentage-of-revenue arrangements can work but must be defensible as fair market value. Flat-fee arrangements tied to specific services are often viewed more favorably by regulators and acquirers alike.

Clinical Independence

The PC must retain genuine authority over all clinical decisions. This means the physician owner has real involvement in hiring clinicians, setting clinical protocols, and overseeing quality of care. If the MSO is making clinical decisions, the structure is a facade that will not hold up.

Consistent Operations

Both entities must operate consistently with their legal structure. The PC should have its own board minutes, financial statements, and compliance records. Management fees should be paid regularly and documented properly. These details matter enormously in due diligence.

The Due Diligence Process

When an acquirer begins due diligence on a healthcare company, the regulatory review typically follows this sequence:

  1. Corporate structure review: Examining formation documents, operating agreements, and the management services agreement
  2. Regulatory compliance assessment: Reviewing CPOM compliance, state licensing, anti-kickback statute considerations, and Stark Law implications if applicable
  3. Financial structure analysis: Evaluating whether management fees are at fair market value and whether the fee structure could be characterized as fee-splitting
  4. Clinician credentialing review: Verifying that all clinicians are properly licensed, credentialed, and supervised according to state requirements
  5. Historical compliance audit: Looking for past violations, complaints, or regulatory actions that could create successor liability

Each of these steps can either accelerate or derail a transaction. Companies that have maintained clean structures from the beginning can move through due diligence in weeks. Companies with structural problems may spend months and significant legal fees trying to remediate issues before a deal can close.

How Structure Impacts Valuation

The impact of MSO-PC structure on valuation goes beyond the binary question of whether a deal closes. Clean structures command premium valuations for several reasons:

In our experience, companies with well-documented MSO-PC structures receive valuations 15-25% higher than comparable companies with structural compliance issues, simply because the acquirer does not need to price in regulatory remediation risk.

Preparing Your Structure for Exit

If you are considering an exit in the next 12 to 24 months, now is the time to ensure your MSO-PC structure is acquisition-ready. Key steps include:

The best time to build a clean MSO-PC structure is at the beginning. The second best time is now. The cost of restructuring before an exit is a fraction of the value lost when structural problems surface during due diligence and either kill a deal or crater your valuation.